Global Meningococcal Vaccine Market

Global Meningococcal Vaccine Market Size, Trends & Analysis with COVID-19 Impact - Forecasts 2026 By Vaccine Type (Conjugate Meningococcal Vaccines, Polysaccharide Vaccine, Subcapsular Vaccines), By Vaccine Serotype (Menacyw Vaccine, Menb/BC Vaccine, Menc Vaccine, Men A Vaccine, Menac Vaccine), By End-User (Pediatrics, Adults, Traveler), By Region (North America, Asia-Pacific, Middle East & Africa, Europe, CSA), End-User Landscape and Company Market Share Analysis and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 16 2024 with the latest and most recent market numbers

Meningococcal Vaccine Market Insights

The meningococcal vaccine market is expected to record high growth during the forecast period. Meningococcal disease is caused by a bacteria called Neisseria meningitidis and can be prevented by vaccine use. Meningococcal vaccines as per the CDC is recommended for teens and pre-teens. The vaccines Men ACWY and MenB tend to produce an immune response. The increase in meningococcal disease in teens is expected to drive the market demand for the vaccine. The uncommon nature of the disease also leads to high use and demand for the vaccines in the market.

Meningococcal Vaccine Market: By Vaccine type

Based on the vaccine, the market is bifurcated into conjugate meningococcal, subcapsular, and polysaccharide vaccines. The conjugate meningococcal will have the largest market penetration during the forecast period. Conjugate meningococcal is proven to show an immune response to the bacteria. They tend to provide protection to the vaccinated and also induce herd immunity. This type of vaccine is recommended for people in the military, HIV infected people, and people residing in a dormitory or other group housing.

Meningococcal Vaccine Market: By Vaccine Serotype

Based on the vaccine serotype, the market is bifurcated into Men A, MenAC, MenB/BC, Men C, and MenACYW vaccine. Men ACYW vaccine serotype is expected to grow rapidly in the market. These vaccines are publicly funded and highly recommended for individuals with factor D deficiency. This vaccine works well and has an 85% protection rate for individuals. Men B/Bc vaccine segment will also be the fastest-growing segment due to their high recommendation for babies aged 8 weeks, 16 weeks, and 1 year. The high protection rate of these vaccines in babies will drive the vaccine growth in the market.

Meningococcal Vaccine Market: By End-User

Based on the end-user, the market is bifurcated into adults, pediatrics, and traveler. The Pediatric and adults end-user segments occupy the largest market share during the forecast period. CDC recommends that the meningococcal vaccine should be necessary for children aged 11 to 12 years. The booster dose is also necessary for children aged 16 years old. The increased risk of meningococcal disease during the adolescent age will drive the high use of booster dose and serogroup B vaccine. The traveler group will also be at the increased risk of this disease which will lead to high usage for this group.

Meningococcal Vaccine Market: By Region

Based on the region, the market is bifurcated into Asia-Pacific, North America, Middle East & Africa, Europe, and CSA. North America region is expected to see the highest use of this vaccine during the forecast period. The rise in the number of patients with meningococcal disease and various immunization programs in the region will augment the vaccine’s demand in the region. The Asia Pacific will also be the fastest-growing region owing to rising general awareness regarding the disease, and rise in traveler base among others.

Meningococcal Vaccine Market Share and Competitive Analysis

Some of the key players operating in the market include Sanofi, Pfizer, GlaxoSmithKline, Bio-Med Private Limited, Serum Institute of India Pvt Ltd, 3S Corporation, Ishita Pharma, Pharmika India Private Limited. Serum Institute of India Pvt Ltd, Lumax Pharmaceutical Private Labs Ltd, and Lotus international.

Please note: This is not an exhaustive list of companies profiled in the report.

Check the Press Release on Global Meningococcal Vaccine Market Report

Meningococcal Vaccine Market: By Vaccine Type

Introduction
1. Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
Conjugate Meningococcal Vaccines
1. Conjugate Meningococcal Vaccines: Meningococcal Vaccine Market, 2018-2026 (USD Million)
Polysaccharide Vaccine
1. Polysaccharide Vaccine: Meningococcal Vaccine Market, 2018-2026 (USD Million)
Subcapsular vaccines
1. Subcapsular vaccines: Meningococcal Vaccine Market, 2018-2026 (USD Million)

Meningococcal Vaccine Market: By End User

Introduction
1. Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
Pediatrics
1. Pediatrics: Meningococcal Vaccine Market, 2018-2026 (USD Million)
Adults
1. Adults: Meningococcal Vaccine Market, 2018-2026 (USD Million)
Traveler
1. Traveler: Meningococcal Vaccine Market, 2018-2026 (USD Million)

Meningococcal Vaccine Market: By Vaccine Serotype

Introduction
1. Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
Menacyw Vaccine
1. Menacyw Vaccine: Meningococcal Vaccine Market, 2018-2026 (USD Million)
Menb/BC Vaccine
1. Menb/BC Vaccine: Meningococcal Vaccine Market, 2018-2026 (USD Million)
MenC Vaccine
1. MenC Vaccine: Meningococcal Vaccine Market, 2018-2026 (USD Million)
Men A Vaccine
1. Men A Vaccine: Meningococcal Vaccine Market, 2018-2026 (USD Million)
MenAC Vaccine
1. MenAC Vaccine: Meningococcal Vaccine Market, 2018-2026 (USD Million)

Meningococcal Vaccine Market: By Region

Introduction
1. Global Meningococcal Vaccine Market, Regional Analysis, 2018-2026 (USD Million)
North America
1. North America Meningococcal Vaccine Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Vaccine Type
    1. North America Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
  2. By Vaccine Serotype
    1. North America Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
  3. By End User
    1. North America Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
  4. By Country
    1. U.S.
      1. By Vaccine Type
        
        U.S Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        U.S Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        U.S Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
    2. Canada.
      1. By Vaccine Type
        
        Canada Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        Canada Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        Canada Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
    3. Mexico
      1. By Vaccine Type
        
        Mexico Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        Mexico Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        Mexico Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
Europe
1. Europe Meningococcal Vaccine Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Vaccine Type
    1. Europe Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
  2. By Vaccine Serotype
    1. Europe Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
  3. By End User
    1. Europe Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
  4. By Country
    1. Germany
      1. By Vaccine Type
        
        Germany Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        Germany Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        Germany Meningococcal Vaccine Market, By Vertical, 2018-2026 (USD Million)
    2. UK
      1. By Vaccine Type
        
        UK Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        UK Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        UK Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
    3. France
      1. By Vaccine Type
        
        France Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        France Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        France Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
    4. Italy
      1. By Vaccine Type
        
        Italy Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        Italy Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        Italy Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
    5. Spain
      1. By Vaccine Type
        
        Spain Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        Spain Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        Spain Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
    6. Rest Of Europe
      1. By Vaccine Type
        
        Rest Of Europe Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        Rest Of Europe Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        Rest Of Europe Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
Asia Pacific
1. Asia Pacific Meningococcal Vaccine Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Vaccine Type
    1. Asia Pacific Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
  2. By Vaccine Serotype
    1. Asia Pacific Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
  3. By End User
    1. Asia Pacific Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
  4. By Country
    1. China
      1. By Vaccine Type
        
        China Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        China Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        China Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
    2. Japan
      1. By Vaccine Type
        
        Japan Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        Japan Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        Japan Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
    3. India
      1. By Vaccine Type
        
        India Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        India Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        India Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
    4. South Korea
      1. By Vaccine Type
        
        South Korea Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        South Korea Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        South Korea Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
    5. Rest Of APAC
      1. By Vaccine Type
        
        Rest Of APAC Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        Rest Of APAC Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        Rest Of APAC Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
Central & South America
1. Central & South America Meningococcal Vaccine Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Vaccine Type
    1. Central & South America Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
  2. By Vaccine Serotype
    1. Central & South America Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
  3. By End User
    1. Central & South America Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
  4. By Country
    1. Brazil
      1. By Vaccine Type
        
        Brazil Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        Brazil Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        Brazil Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
Middle East & Africa
1. Middle East & Africa Meningococcal Vaccine Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Vaccine Type
    1. Middle East & Africa Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
  2. By Vaccine Serotype
    1. Middle East & Africa Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
  3. By End User
    1. Middle East & Africa Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
  4. By Country
    1. Saudi Arabia
      1. By Vaccine Type
        
        Saudi Arabia Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        Saudi Arabia Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        Saudi Arabia Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)
    2. UAE
      1. By Vaccine Type
        
        UAE Meningococcal Vaccine Market, By Vaccine Type, 2018-2026 (USD Million)
      2. By Vaccine Serotype
        
        UAE Meningococcal Vaccine Market, By Vaccine Serotype, 2018-2026 (USD Million)
      3. By End User
        
        UAE Meningococcal Vaccine Market, By End User, 2018-2026 (USD Million)

The global Meningococcal Vaccine Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Meningococcal Vaccine Market.

Meningococcal Vaccine Market

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Meningococcal Vaccine Market

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.

Meningococcal Vaccine Market